Patent ID: 11919926
Assignee: ESTEVE PHARMACEUTICALS, S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 24:
25. An immunogenic fusion polypeptide, comprising:
i) an N-terminal signal peptide;
ii) an amino acid sequence having the amino acid sequence of SEQ ID NO: 2;
iii) an amino acid sequence having the amino acid sequence of SEQ ID NO: 3;
iv) an amino acid sequence having the amino acid sequence of SEQ ID NO: 4;
v) an amino acid sequence having the amino acid sequence of SEQ ID NO: 5;
vi) an amino acid sequence having the amino acid sequence of SEQ ID NO: 6;
vii) an amino acid sequence having the amino acid sequence of SEQ ID NO: 7;
viii) an amino acid sequence having the amino acid sequence of SEQ ID NO: 8;
ix) an amino acid sequence having the amino acid sequence of SEQ ID NO: 10;
x) an amino acid sequence having the amino acid sequence of SEQ ID NO: 12; and
xi) an amino acid sequence having the amino acid sequence of SEQ ID NO: 13.